Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Acta neurochirurgica. Supplement

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-211-98811-4_32PMID 19812944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation between Choline Signal Intensity and Acetylcholine Level in Different Brain Regions of Rat

  2008cited by this paper
• Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

  2008cited by this paper
• Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

  2007cited by this paper
• Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.

  2007cited by this paper
• Plaques and tangles and the pathogenesis of Alzheimer's disease.

  2006cited by this paper
• Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease

  2006cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• Glutamatergic Neurotransmission and Neuronal Glucose Oxidation are Coupled during Intense Neuronal Activation

  2004cited by this paper
• Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats.

  2003cited by this paper
• Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain.

  1999cited by this paper
• Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

  1998cited by this paper
• Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease

  1998cited by this paper
• Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

  1998cited by this paper
• Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease.

  1997cited by this paper
• Altered cerebral energy metabolism in Alzheimer's disease: a PET study.

  1994cited by this paper
• Estimation of metabolite concentrations from localized in vivo proton NMR spectra

  1993influential reference
• Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease.

  1990cited by this paper
• Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone

  1987cited by this paper
• Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease

  1987cited by this paper

• Neurotrophic Factor Neuritin Ameliorates Streptozotocin-Induced Alzheimer's Disease-Like Impairment of Memory, Neuroinflammation, Apoptotic Factors and Compensates Hippocampal Neuritin Expression.

  2025cites this paper
• Murine Non-Transgenic Models of Alzheimer’s Disease Pathology: Focus on Risk Factors

  2025cites this paper
• Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease

  2025cites this paper
• Lycium Barbarum Polysaccharides Improves Cognitive Functions in ICV-STZ-Induced Alzheimer’s Disease Mice Model by Improving the Synaptic Structural Plasticity and Regulating IRS1/PI3K/AKT Signaling Pathway

  2024cites this paper
• Effect of mesenchymal stem cells and polyvinyl alcohol-coated selenium nanoparticles on rats with Alzheimer-like phenotypes

  2024cites this paper
• Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with 11C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy.

  2024cites this paper
• Pre- and post-treatment of α-Tocopherol on cognitive, synaptic plasticity, and mitochondrial disorders of the hippocampus in icv-streptozotocin-induced sporadic Alzheimer’s-like disease in male Wistar rat

  2023cites this paper
• Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs

  2023cites this paper
• Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia

  2022cites this paper
• Metabolic alterations in the visual pathway of retinitis pigmentosa rats: A longitudinal multimodal magnetic resonance imaging study with histopathological validation

  2022cites this paper
• Riluzole restores memory and brain energy metabolism in AβPP-PS1 mouse model of Alzheimer's disease.

  2022cites this paper
• A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer’s Disease and Diabetes

  2022cites this paper
• Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: Involvement of nitric oxide status, Aβ extrusion transporter ABCB1, and reversal by PKA inhibitor H89.

  2021cites this paper
• Tadalafil modulates intracerebroventricular streptozotocin-induced cognition and memory impairment in the young and middle middle-aged rats

  2021cites this paper
• Brain energy metabolism in intracerebroventricularly administered streptozotocin mouse model of Alzheimer’s disease: A 1H-[13C]-NMR study

  2021cites this paper
• Ferroptosis-Related Genes in Neurodevelopment and Central Nervous System

  2021cites this paper
• Saffron and Neurological Disorders

  2020cites this paper
• The novel GLP‐1/GIP analogue DA5‐CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD

  2020cites this paper
• Atorvastatin has therapeutic potential for the fatty liver-induced memory dysfunction in rats, likely via its antioxidant and anti-inflammatory properties

  2020cites this paper
• Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer’s-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway

  2020cites this paper
• Ruthenium red, mitochondrial calcium uniporter inhibitor, attenuates cognitive deficits in STZ-ICV challenged experimental animals.

  2020cites this paper
• Sex-specific metabolic alterations in the type 1 diabetic brain of mice revealed by an integrated method of metabolomics and mixed-model

  2020cites this paper
• Nutritional and health beneficial properties of saffron (Crocus sativus L): a comprehensive review

  2020cites this paper
• Intracerebroventricular streptozotocin administration impairs mitochondrial calcium homeostasis and bioenergetics in memory-sensitive rat brain regions

  2020cites this paper
• Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.

  2020cites this paper
• Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla.

  2019cites this paper
• Antioxidant Properties of Crocus Sativus L. and Its Constituents and 
Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and 
Parkinson’s Disease

  2019cites this paper
• Anti-Nogo-A antibody promotes brain function recovery after cardiopulmonary resuscitation in rats by reducing apoptosis

  2019cites this paper
• Quantitation of in vivo brain glutathione conformers in cingulate cortex among age‐matched control, MCI, and AD patients using MEGA‐PRESS

  2019cites this paper
• Protective Effects of 5-HT1A Receptor Inhibition and 5-HT2A Receptor Stimulation Against Streptozotocin-Induced Apoptosis in the Hippocampus

  2019cites this paper
• Simvastatin Attenuates Hippocampal MMP-9 Expression in the Streptozotocin-Induced Cognitive Impairment

  2019cites this paper
• Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta‐analysis in human pathological specimens

  2018cites this paper
• A comprehensive review of the pharmacological potential of Crocus sativus and its bioactive apocarotenoids.

  2018cites this paper
• Targeting central &bgr;2 receptors ameliorates streptozotocin‐induced neuroinflammation via inhibition of glycogen synthase kinase3 pathway in mice

  2018cites this paper
• Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology

  2018cites this paper
• The effects of the 5-HT7 receptor on hippocampal long-term potentiation and apoptosis in a rat model of Alzheimer's disease.

  2017cites this paper
• Gclc deficiency in mouse CNS causes mitochondrial damage and neurodegeneration

  2017cites this paper
• The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer’s Disease, Based on a Mechanistic Target of Rapamycin Pathway

  2017cites this paper
• Vitamin D3 attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer’s disease

  2017cites this paper
• Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.

  2017cites this paper
• Reducing the effects of drug toxicity on glutathione metabolism

  2016cites this paper
• Icariside II, a novel phosphodiesterase-5 inhibitor, attenuates streptozotocin-induced cognitive deficits in rats.

  2016cites this paper
• KISSPEPTIN-13 AMELIORATES MEMORY IMPAIRMENT INDUCED BY STREPTOZOTOCIN IN MALE RATS VIA CHOLINERGIC SYSTEM

  2016cites this paper
• The effects of Crocus sativus (saffron) and its constituents on nervous system: A review

  2015cites this paper
• Hippocampal DHCR24 down regulation in a rat model of streptozotocin-induced cognitive decline.

  2015cites this paper
• Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology

  2015cites this paper
• Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism

  2015cites this paper
• A Pilot In Vivo Proton Magnetic Resonance Spectroscopy Study of Amino Acid Neurotransmitter Response to Ketamine Treatment of Major Depressive Disorder

  2015cites this paper
• Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.

  2015cites this paper
• Trimetazidine prevents oxidative changes induced in a rat model of sporadic type of Alzheimer's disease.

  2015cites this paper
• Brain metabolic dysfunction at the core of Alzheimer's disease.

  2014cites this paper
• Detection of bacterial antigens and Alzheimer’s disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae

  2014cites this paper
• Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.

  2014cites this paper
• Oral Inflammation, Tooth Loss, Risk Factors, and Association with Progression of Alzheimer's Disease

  2014cites this paper
• Silibinin ameliorates LPS-induced memory deficits in experimental animals.

  2014cites this paper
• The Emerging Role of Glutathione in Alzheimer's Disease

  2014cites this paper
• Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease

  2014cites this paper
• Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model.

  2014cites this paper
• Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease.

  2013cites this paper
• The Janus Face of Insulin in Brain

  2013cites this paper
• Hypoglycemia induces tau hyperphosphorylation.

  2013cites this paper
• Elevated CSF and plasma microparticles in a rat model of streptozotocin-induced cognitive impairment.

  2013cites this paper
• Insulin Resistance and Metabolic Failure Underlie Alzheimer Disease

  2013cites this paper
• CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer’s Disease

  2013cites this paper
• (Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type.

  2012cites this paper
• 2 Evidence for an Infectious Etiology in Alzheimer ’ s Disease

  2012cites this paper
• Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

  2012cites this paper
• Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease.

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Triangulated Mal-Signaling in Alzheimer's Disease: Roles of Neurotoxic Ceramides, ER Stress, and Insulin Resistance Reviewed

  2012cites this paper
• The effect of oral feeding of Withania somnifera L. alcoholic extract on intracerebroventricular streptozotocin-induced cognitive deficits in male rat

  2012cites this paper
• Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimer’s Disease

  2012cites this paper
• Insulin Resistance, Cognitive Impairment and Neurodegeneration: Roles of Nitrosamine Exposure, Diet and Lifestyles

  2011cites this paper
• Dementia, Diabetes, Alzheimer's Disease, and Insulin Resistance in the Brain: Progress, Dilemmas, New Opportunities, and a Hypothesis to Tackle Intersecting Epidemics

  2011cites this paper
• Evidence for an Infectious Etiology in Alzheimer’s Disease

  2011cites this paper
• Magnetic resonance in studies of glaucoma

  2011cites this paper
• The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

  2011cites this paper
• Metabolic changes in visual cortex of neonatal monocular enucleated rat: a proton magnetic resonance spectroscopy study

  2011cites this paper
• etabolic changes in visual cortex of neonatal monocular enucleated rat : a roton magnetic resonance spectroscopy study pril

  2010cites this paper
• Effects of active constituents of Crocus sativus L., crocin on streptozocin-induced model of sporadic Alzheimer's disease in male rats.

  2010cites this paper
• NEUROLOGY AND PRECLINICAL NEUROLOGICAL STUDIES - ORIGINAL ARTICLE

  year unknowncites this paper